CO42 Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Anaemia of Chronic Kidney Disease: A Systematic Literature Review
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.121
https://www.valueinhealthjournal.com/article/S1098-3015(22)02325-7/fulltext
Title :
CO42 Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Anaemia of Chronic Kidney Disease: A Systematic Literature Review
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02325-7&doi=10.1016/j.jval.2022.09.121
First page :
Section Title :
Open access? :
No
Section Order :
10775